ReviewCureus2025
Extrapulmonary Nontuberculous Mycobacteria Infection: The New-Age Neglected Infectious Disease.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Organelle interplay in host responses and mycobacterial resilience.EMBO reports · 2026Review
- Cutaneous MAC infection in an immunocompetent patient: a case report confirmed by mNGS.BMC infectious diseases · 2026Article
- Non-tubercular mycobacterial infections: Emerging from the shadows.Lung India : official organ of Indian Chest Society · 2026Article
- Patient's features, clinical patterns and outcomes of non-tuberculous mycobacteria infections: A 10-year retrospective analysis from a third level university hospital.Journal of clinical tuberculosis and other mycobacterial diseases · 2026Article
- Advanced diagnostic methods for nontuberculous mycobacterial infections.Frontiers in tuberculosis · 2026Review
- Diagnosis of nontuberculous mycobacterial infections using genomics and artificial intelligence-machine learning approaches: scope, progress and challenges.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nontuberculous mycobacteria (NTM), otherwise known as atypical mycobacteria, primarily cause pulmonary disease. However, with the increase in the immunocompromised population, infections caused by NTM at extrapulmonary (EP) sites have been on the rise in the past decade. Clinical presentations can commonly include lymphadenitis and skin and soft tissue infections. The diagnosis is challenging due to the invasive nature of the sample collection and the low degree of suspicion. Furthermore, detection up to the speciation level is important as management is species-specific. With limited data and studies regarding extrapulmonary nontuberculous mycobacteria (EP-NTM) disease, a multidisciplinary approach with awareness is required to recognize the pathogen early for appropriate and timely institution of therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.